31 st March, 2018 which was reviewed by authorized Auditor with the details as follows: The total revenues of the Company and its Subsidiaries in the Quarter 1/2018 was 165.55 million Baht, an increase
. The objective of this MD&A is to present the information and the explanation of financial status and operating results as of the date hereof. However, the information provided in this MD&A may vary if
performance are as follows: Sales Revenue Sales revenue for Q2/2017 of 269.33 million baht shows an increase of 99.98 million baht or 59.04% y-o-y. Cost of sales of 172.40 million baht shows an increase of
to the same period of previous year which a net loss of Baht 5.43 million, the loss increase Baht 7.45 million or increase by 137.09% , the main reasons are as follow 1. Revenue from sale , Other
June 12, 2018 Subject Increase of Registered Capital, Allocation and Offering of the Newly Issued Ordinary Shares to a Specific Investor (Private Placement), Application for Waiver from the Requirement
Company expects the production capacity to increase from around 59,000 tons/year on 31 March 2017 to around 78,000 tons/year. 1.7.2 The objective for the acquisition of property is to build a factory
has fully - paid of 10 Baht per share, totally in 1,000,000 Baht. Registering capital increase on September 18, 2017 in 12,900,000 shares a price at 10 Baht per share paid – up of 7.80038 Baht
transaction. 6. Transaction objective : To manage obsolete assets properly. To increase the Company’s liquidity, decrease administrative expenses and prepare the land for any other businesses in the future. 7
increase liquidity and support the expansion of core business. 6. Characteristics and scope of interests of connected persons when agreeing to enter into the connected transaction PRG is a major shareholder
objective of the investment Investment in N Hospital Co.,Ltd which engaging in healthcare business, hospital, pharmaceuticals and medical equipment. The Company will do within December 10, 2019. 2. The